S J Dencker, K Frankenberg, U Malm, B Zell. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAgedAntiparkinson Agents/therapeutic useAntipsychotic Agents/administration & dosageAntipsychotic Agents/adverse effectsAntipsychotic Agents/therapeutic useBasal Ganglia Diseases/chemically inducedClinical Trials as TopicDiazepam/therapeutic useDrug EvaluationFemaleFluphenazine/adverse effectsFluphenazine/therapeutic useHumansImipramine/therapeutic useInjectionsMaleMiddle AgedPalmitic Acids/therapeutic usePiperidines/administration & dosagePiperidines/adverse effectsPiperidines/therapeutic usePsychiatric Status Rating ScalesSchizophrenia/drug therapySulfonamides/adverse effectsSulfonamides/therapeutic useTime Factors
Substances： See more » Antiparkinson AgentsAntipsychotic AgentsPalmitic AcidsPiperidinesSulfonamidesImipramineDiazepamFluphenazine
Year: 1973 PMID： 4147508 DOI： 10.1111/j.1600-0447.1973.tb07048.x
Source DB: PubMed Journal: Acta Psychiatr Scand Suppl ISSN： 0065-1591